Metabolic acidosis is a frequent and potentially serious medical condition that occurs when the body produces too much acid or when the kidneys are not able to effectively remove acid from the body. Non-anion gap metabolic acidosis (NAGMA) is a specific type of metabolic acidosis that occurs when there is an accumulation of organic acids, such as lactic acid, in the body. This type of acidosis is typically caused by a variety of medical conditions, such as kidney failure, certain medications, and certain genetic disorders. In this article, we will explore the causes and treatment options for NAGMA. We will discuss the various medical conditions that can cause NAGMA, the medications that can contribute to this condition, and the genetic disorders that can lead to NAGMA. We will also discuss the various treatments available for NAGMA, including lifestyle changes, medications, and other treatments.
Non-anion gap metabolic acidosis (NAGMA) is a type of metabolic acidosis that occurs when there is an accumulation of organic acids, such as lactic acid, in the body. This type of acidosis is typically caused by a variety of medical conditions, such as kidney failure, certain medications, and certain genetic disorders. NAGMA is a type of metabolic acidosis that is characterized by an abnormally high level of acid in the blood. The acidity of the blood is measured using the anion gap, which is the difference between the concentrations of the two main types of electrolytes in the blood: anions and cations. In NAGMA, the anion gap is normal, meaning that the levels of anions and cations are equal.
What Causes Non-Anion Gap Metabolic Acidosis?
NAGMA is typically caused by a variety of medical conditions, medications, and genetic disorders. The most common causes of NAGMA include:
Kidney Failure
Kidney failure is one of the most common causes of NAGMA. When the kidneys are not functioning properly, they are unable to filter out the acids that are produced in the body, leading to an accumulation of acid in the blood.
Medications
Certain medications, such as diuretics and antifungal medications, can also cause NAGMA. These medications can interfere with the body’s ability to filter out acids, leading to an accumulation of acid in the blood.
Genetic Disorders
Certain genetic disorders, such as inherited metabolic disorders, can also lead to NAGMA. These disorders can interfere with the body’s ability to process and eliminate acids, leading to an accumulation of acid in the blood.
The treatment of NAGMA depends on the underlying cause of the condition. In some cases, lifestyle changes may be enough to reduce the acid levels in the blood. In other cases, medications may be needed to reduce the acid levels in the blood. In some cases, other treatments, such as dialysis, may be necessary.
Non-anion gap metabolic acidosis (NAGMA) is a type of metabolic acidosis that occurs when there is an accumulation of organic acids, such as lactic acid, in the body. NAGMA is typically caused by a variety of medical conditions, medications, and genetic disorders. The treatment of NAGMA depends on the underlying cause of the condition, and may include lifestyle changes, medications, and other treatments.
1.
Sub-Q Ketamine is Safe and Very Effective for Severe Depression.
2.
Study indicates that exercise can help colon cancer survivors live as long as matched individuals
3.
Contradictory Results Are Found in Two Pembrolizumab Trials for Head and Neck Cancer.
4.
Can Concurrent Boost Safely Shorten Breast Cancer Radiation?
5.
Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.
1.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
2.
Antibody-Drug Conjugates in Oncology: Breakthroughs, Clinical Updates, and Pipeline Innovation
3.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
4.
Polycythemia Vera: A Historical Perspective and Contemporary Management
5.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation